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Introduction
Chronic atypical neutrophilic dermatosis with lipody-
strophy and elevated temperature (CANDLE) syndrome
is a newly described autoinflammatory disease.
Objectives
To describe clinical phenotype and cytokine profile of our
patient.
Methods
A 10 year-old young girl presented at 10 months of age
with recurrent fever, hepato-splenomegaly and nodular
erythematous skin lesions of trunk and limbs; subse-
quently she progressively developed lypodistrophy,
arthralgia, arthritis and edema of eyelids. Skin biopsy
showed typical features of lobular panniculitis. Labora-
tory tests showed persistent elevated acute phase reac-
tants with increased serum amyloid A, persistent chronic
anemia, mild recurrent leucopenia, thrombocytopenia
and decreased IgA, IgG and IgM levels. Immunological
and cytogenetic studies performed on bone marrow were
normal. Subsequently, the patient developed proteinuria
with nephrotic syndrome. Renal biopsy revealed a mini-
mal change glomerulopathy; she was started on a stan-
dard nephrotic syndrome high-dose glucocorticoid
protocol with remission of proteinuria. Response to
hydroxychlorochine, colchicine, cyclosporine-A, and ana-
kinra was unsatisfactory. Complete sequencing of
TNFRSF1A and MVK genes showed no mutations. Ana-
lysis of the PSMB8 (proteasome subunit b type 8) gene
revealed the presence of c.220A>T p.(T74S) variant in
heterozygotic status that has never been reported before.
In order to assess the dysregulated inflammatory
response in our patient, we evaluated the cytokine profile
in patient’s sera using the Luminex multiplexing assay.
Whole blood RNA analysis was also performed using a
human immune array (TaqMan® Human Immune Array
from Applied Biosystems), containing 92 genes typically
involved in the immune response.
Results
Serum samples (n=4) were collected during the last two
years. We found high levels of IFN gamma (mean ± S.D.:
115.3 pg/ml ± 64.21), of IFN-gamma inducible protein 10
(IP-10, also called CXCL10) (1641± 892.5 pg/ml) and of
IFN-gamma inducible protein 9 (IP-9, also called
CXCL11) (582.9± 335.6 pg/ml) and especially of CXCL9,
also known as monokine induced by gamma interferon
(MIG) (18161± 6405 pg/ml), compared to healthy con-
trols or pediatric patients with sJIA during active disease.
Two whole blood RNA samples collected from our
Candle patient were compared to 6 whole blood RNA
samples collected from healthy controls comparable for
age. We obtained results consistent with those obtained
by serum cytokine measurement: IFNg, CXCL10 and
CXCL11 mRNA expression were significantly increased
compared to healthy controls (1.88, 32.7 and 4.1 fold
higher respectively). We also found that the expression of
the HLA-DRB1, a gene whose expression is known to
be induced by IFN-gamma, was markedly upregulated
(> 100.000 fold increase) compared to healthy controls.
Conclusion
In conclusion, we describe a typical CANDLE clinical phe-
notype in the absence of biallelic mutations of PSMB8
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gene. The presence of high levels of IFN-g and of IFN-g
related chemokines points to a major pathogenic role of
the IFN-g pathway, which appears to be similar to what
has been recently reported in CANDLE (Liu et al). The
pathogenic role of the variant T74S remains to be eluci-
dated: a potential role is suggested by its presence in a
patient with a classical phenotype and with a dysregulation
of the IFN pathway, taking also into account that this
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